Insmed Inc

INSM

Equity

ISIN null / Valor 12614415

NASDAQ (2026-09-29)

USD 115.63-1.73%

Insmed Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare and severe diseases, particularly targeting pulmonary conditions. The company's portfolio includes inhaled pharmaceuticals designed to treat various lung diseases, and it has expanded its pipeline through strategic acquisitions, such as Celtrix Pharmaceuticals, and partnerships like a worldwide license agreement with AstraZeneca. Following its transition to a public company, Insmed continues to advance clinical programs across its four strategic pillars, aiming to deliver meaningful clinical data and address unmet medical needs in the rare disease sector. Headquartered in Bridgewater, New Jersey, Insmed leverages its expertise and collaborative efforts to drive growth and enhance its position in the specialized pharmaceutical market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-18.4%1Y

358%3Y

341%5Y

Performance

61.6%1Y

67.8%3Y

62.0%5Y

Volatility